Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Catalysis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN116730915A enables metal-free asymmetric catalysis. Offers high purity pharmaceutical intermediates with reduced cost and scalable supply chain solutions.
Patent CN113444125A reveals high-ee ligand for alkaloid synthesis. Enables cost reduction in pharmaceutical intermediates manufacturing with scalable supply chain reliability.
Patent CN104557851B reveals a novel catalytic route for Eliglustat intermediates. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical partners.
Discover high-purity axial chiral 4-aryl alpha-carboline intermediates synthesized via novel NHC organocatalysis. Reliable supply chain solutions for pharmaceutical manufacturing.
Patent CN110240543B details a continuous flow synthesis for Vitamin A intermediates, offering higher yields and simplified purification for reliable supply chains.
Patent CN110776470B details an iridium-catalyzed asymmetric hydrogenation method for chiral 3,4-dihydroquinazolinones with up to 98% ee, offering a scalable route for API intermediates.
Patent CN114790151A reveals a cost-effective composite catalytic route for methyl 2-cyano-2-valproate, offering significant supply chain advantages for valproamide manufacturing.
Discover a green, metal-free method for synthesizing 2-substituted 3-methylindole derivatives using g-C3N4 photocatalysis, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN117448309A reveals biocatalytic synthesis for high-purity pregabalin intermediates. Achieve significant cost reduction and supply chain reliability.
Novel Ti-Ni catalytic method for allyl alcohol compounds reduces costs and improves supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111270260B reveals a green Rh-catalyzed C-H activation route using electricity, offering cost-effective API intermediate manufacturing without external oxidants.
Patent CN109553538B reveals continuous fixed-bed catalysis for high-purity 1 2-cyclohexanediamine. This breakthrough ensures supply chain stability and cost efficiency.
Patent CN106631740A details a novel NHC-catalyzed route for cyclopent-2-enone-4-ols. Offers high dr, mild conditions, and supply chain advantages for pharma intermediates.
Novel esterase mutant enables high-yield chiral intermediate production. Reduces cost and improves supply chain reliability for pharmaceutical manufacturing.
Advanced electrochemical synthesis of CBS rubber accelerators ensures high purity and cost efficiency for global polymer supply chains. Discover sustainable manufacturing solutions.
Analysis of patent CN108947801A reveals a novel ionic liquid method for high-purity 4,4'-Biphenyldicarboxylic acid, offering substantial cost reduction in polymer materials manufacturing.
Discover a green, mild process for preparing aryl thioamide compounds using benzyl alcohol and sulfur. Ideal for cost reduction in pharmaceutical intermediate manufacturing.
Patent CN104651243A reveals a biocatalytic route for (R)-1,3-butanediol. Offers high purity and yield for antibiotic synthesis, ensuring reliable supply chain solutions.
Patent CN106868534B enables mild electro-catalytic synthesis. Delivers high-purity bile acids with substantial cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Patent CN119823958A details a ketoreductase mutant for synthesizing chiral intermediates. This report analyzes supply chain stability and cost reduction in pharmaceutical intermediates manufacturing.